Medical Weight Loss for Cleveland, Ohio Residents

Cleveland, Ohio residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Cleveland through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Cleveland: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Ohio. Results vary. Doctor review just $119 (medication separate).

Why Cleveland Residents Choose New Hope Weight Loss

A lot of clinics talk about supervision in the abstract. We can name the person doing it. Dr. Anjmun Sharma, MD oversees every Cleveland case personally, which means your dose, your check-ins, and your safety calls are decisions a single physician owns from start to finish. Compounded GLP-1 medication deserves that kind of continuity, and we would rather give you one accountable doctor than a queue of interchangeable ones.

Cleveland is served through telehealth from our Costa Mesa, California clinic. The physician consultation, prescription, and follow-up all happen by secure video.

People throughout Cleveland reach the same physician-supervised care that built our reputation in Costa Mesa, and they do it from home, because telehealth erases the gap between Ohio and California. We care for patients throughout Downtown, Ohio City, Tremont, University Circle, and the greater Cleveland area. Compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical, and Dr. Sharma will walk you through what that means for you in plain terms.

Your zip code inside Ohio does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Cleveland patients it starts at $166 per month, billed separately. New Hope Weight Loss serves patients throughout Ohio entirely by telehealth from our Costa Mesa, California clinic, bringing physician-supervised programs to your home without an office visit.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Cleveland meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Cleveland

The path from curious to treated is short, and it all runs through your screen. People in Cleveland start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Cleveland home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Cleveland

How does someone in Cleveland access New Hope Weight Loss?

Access from Cleveland is entirely online. Our one physical clinic stands in Costa Mesa, California, while we serve Cleveland, Ohio through telehealth. To begin, Dr. Anjmun Sharma meets you over secure video, reviews your background, and confirms whether you are eligible for a compounded GLP-1 program.

Is a clinic visit part of the process for Cleveland residents?

A clinic visit is never part of it for Cleveland. The model is fully telehealth, so your consult, refills, and check-ins happen from home. After Dr. Sharma approves you, medication is shipped to Cleveland inside cold-pack packaging designed to maintain a steady temperature during transit.

What are the fees for Cleveland patients?

The physician review costs $119. Compounded semaglutide runs from $166 each month, or $499 for the 90-day program, and tirzepatide from $233 each month. Medication is billed on its own. We honor HSA, FSA, Klarna, and Affirm, and Cleveland residents are charged no distance surcharge.

What areas of Cleveland do you serve?

We serve patients from across Cleveland by telehealth, including Downtown, Ohio City, Tremont, University Circle, and the greater Cleveland area.

Can Cleveland patients get treatment without traveling?

Yes. Cleveland patients complete the entire program, intake, physician consultation with Dr. Sharma, dose titration, and follow-up, by telehealth, with compounded medication shipped to their Cleveland address.

Cleveland Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Cleveland, Ohio by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.